Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Current and future treatments for tuberculosis
The BMJ, Volume 368, Article m216, Year 2020
Notification
URL copied to clipboard!
Description
Guidelines on the treatment of tuberculosis (TB) have essentially remained the same for the past 35 years, but are now starting to change. Ongoing clinical trials will hopefully transform the landscape for treatment of drug sensitive TB, drug resistant TB, and latent TB infection. Multiple trials are evaluating novel agents, repurposed agents, adjunctive host directed therapies, and novel treatment strategies that will increase the probability of success of future clinical trials. Guidelines for HIV-TB co-infection treatment continue to be updated and drug resistance testing has been revolutionized in recent years with the shift from phenotypic to genotypic testing and the concomitant increased speed of results. These coming changes are long overdue and are sorely needed to address the vast disparities in global TB incidence rates. TB is currently the leading cause of death globally from a single infectious agent, but the work of many researchers and the contributions of many patients in clinical trials will reduce the substantial global morbidity and mortality of the disease. © Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to.
Authors & Co-Authors
Xie, Yingda Linda
United States, Bethesda
National Institutes of Health Nih
United States, Newark
Rutgers new Jersey Medical School
Barry, Clifton Earl
United States, Bethesda
National Institutes of Health Nih
Chen, Ray Y.
United States, Bethesda
National Institutes of Health Nih
Statistics
Citations: 38
Authors: 3
Affiliations: 2
Identifiers
Doi:
10.1136/bmj.m216
ISSN:
09598146
Research Areas
Infectious Diseases
Study Design
Cohort Study